메뉴 건너뛰기




Volumn 198, Issue 4, 2008, Pages 477.e1-477.e10

Erratum: Impact of vessel maturation on antiangiogenic therapy in ovarian cancer (American Journal of Obstetrics and Gynecology (2008) 198(4) (477.e1–477.e10), (S000293780702340X) (10.1016/j.ajog.2007.12.028));Impact of vessel maturation on antiangiogenic therapy in ovarian cancer

Author keywords

endothelial cells; ovarian cancer; PDGF; pericytes; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; IMATINIB; LIGAND; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

EID: 41349089301     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2018.04.029     Document Type: Erratum
Times cited : (56)

References (37)
  • 1
    • 0030265393 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and its receptors
    • Klagsbrun M., and D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7 (1996) 259-270
    • (1996) Cytokine Growth Factor Rev , vol.7 , pp. 259-270
    • Klagsbrun, M.1    D'Amore, P.A.2
  • 2
    • 33746851955 scopus 로고    scopus 로고
    • Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
    • Thaker P.H., Han L.Y., Kamat A.A., et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12 (2006) 939-944
    • (2006) Nat Med , vol.12 , pp. 939-944
    • Thaker, P.H.1    Han, L.Y.2    Kamat, A.A.3
  • 3
    • 0037699954 scopus 로고    scopus 로고
    • The biology of VEGF and its receptors
    • Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
    • (2003) Nat Med , vol.9 , pp. 669-676
    • Ferrara, N.1    Gerber, H.P.2    LeCouter, J.3
  • 4
    • 0028803509 scopus 로고
    • Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
    • Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1 (1995) 1024-1028
    • (1995) Nat Med , vol.1 , pp. 1024-1028
    • Alon, T.1    Hemo, I.2    Itin, A.3    Pe'er, J.4    Stone, J.5    Keshet, E.6
  • 5
    • 19244379078 scopus 로고    scopus 로고
    • Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    • Carmeliet P., Moons L., Luttun A., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7 (2001) 575-583
    • (2001) Nat Med , vol.7 , pp. 575-583
    • Carmeliet, P.1    Moons, L.2    Luttun, A.3
  • 6
    • 0029004025 scopus 로고
    • Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
    • Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
    • (1995) Am J Pathol , vol.146 , pp. 1029-1039
    • Dvorak, H.F.1    Brown, L.F.2    Detmar, M.3    Dvorak, A.M.4
  • 7
    • 0036793818 scopus 로고    scopus 로고
    • Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer
    • Cooper B.C., Ritchie J.M., Broghammer C.L., et al. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 8 (2002) 3193-3197
    • (2002) Clin Cancer Res , vol.8 , pp. 3193-3197
    • Cooper, B.C.1    Ritchie, J.M.2    Broghammer, C.L.3
  • 8
    • 33751006991 scopus 로고    scopus 로고
    • Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer
    • Hefler L.A., Zeillinger R., Grimm C., et al. Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer. Gynecol Oncol 103 (2006) 512-517
    • (2006) Gynecol Oncol , vol.103 , pp. 512-517
    • Hefler, L.A.1    Zeillinger, R.2    Grimm, C.3
  • 9
    • 3242658330 scopus 로고    scopus 로고
    • Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer
    • Li L., Wang L., Zhang W., et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res 24 (2004) 1973-1979
    • (2004) Anticancer Res , vol.24 , pp. 1973-1979
    • Li, L.1    Wang, L.2    Zhang, W.3
  • 10
    • 0030923795 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression in early stage ovarian carcinoma
    • Paley P.J., Staskus K.A., Gebhard K., et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80 (1997) 98-106
    • (1997) Cancer , vol.80 , pp. 98-106
    • Paley, P.J.1    Staskus, K.A.2    Gebhard, K.3
  • 11
    • 33846933952 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies
    • Frumovitz M., and Sood A.K. Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol 104 (2007) 768-778
    • (2007) Gynecol Oncol , vol.104 , pp. 768-778
    • Frumovitz, M.1    Sood, A.K.2
  • 12
    • 36849019301 scopus 로고    scopus 로고
    • Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group study
    • Burger R., Sill M., Monk B., Greer B., and Sorosky J. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group study. J Clin Oncol 25 (2007) 5165-5171
    • (2007) J Clin Oncol , vol.25 , pp. 5165-5171
    • Burger, R.1    Sill, M.2    Monk, B.3    Greer, B.4    Sorosky, J.5
  • 13
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 14
    • 30944446883 scopus 로고    scopus 로고
    • Lessons from phase III clinical trials on anti-VEGF therapy for cancer
    • Jain R.K., Duda D.G., Clark J.W., and Loeffler J.S. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3 (2006) 24-40
    • (2006) Nat Clin Pract Oncol , vol.3 , pp. 24-40
    • Jain, R.K.1    Duda, D.G.2    Clark, J.W.3    Loeffler, J.S.4
  • 15
    • 41349088227 scopus 로고    scopus 로고
    • Role of pericytes in angiogenesis
    • Teicher B.A., and Ellis L.M. (Eds), Humana Press, Inc, Totowa (NJ)
    • Lu C., and Sood A. Role of pericytes in angiogenesis. In: Teicher B.A., and Ellis L.M. (Eds). Angiogenesis agents in cancer therapy. 2nd ed. (2008), Humana Press, Inc, Totowa (NJ) 117-132
    • (2008) Angiogenesis agents in cancer therapy. 2nd ed. , pp. 117-132
    • Lu, C.1    Sood, A.2
  • 17
    • 0016730816 scopus 로고
    • Tridimensional views of the relationship of pericytes to endothelial cells of capillaries in the human choroid and retina
    • (Tokyo)
    • Matsusaka T. Tridimensional views of the relationship of pericytes to endothelial cells of capillaries in the human choroid and retina. J Electron Microsc 24 (1975) 13-18 (Tokyo)
    • (1975) J Electron Microsc , vol.24 , pp. 13-18
    • Matsusaka, T.1
  • 18
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
    • (2000) Nature , vol.407 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 19
    • 0035972251 scopus 로고    scopus 로고
    • Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis
    • Hellstrom M., Gerhardt H., Kalen M., et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153 (2001) 543-553
    • (2001) J Cell Biol , vol.153 , pp. 543-553
    • Hellstrom, M.1    Gerhardt, H.2    Kalen, M.3
  • 20
    • 0038476608 scopus 로고    scopus 로고
    • Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
    • Bergers G., Song S., Meyer-Morse N., Bergsland E., and Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111 (2003) 1287-1295
    • (2003) J Clin Invest , vol.111 , pp. 1287-1295
    • Bergers, G.1    Song, S.2    Meyer-Morse, N.3    Bergsland, E.4    Hanahan, D.5
  • 21
    • 34547100525 scopus 로고    scopus 로고
    • Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma
    • Lu C., Kamat A., Lin Y.G., et al. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res 13 (2007) 4209-4217
    • (2007) Clin Cancer Res , vol.13 , pp. 4209-4217
    • Lu, C.1    Kamat, A.2    Lin, Y.G.3
  • 22
    • 0030756325 scopus 로고    scopus 로고
    • Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
    • Lindahl P., Johansson B.R., Leveen P., and Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997) 242-245
    • (1997) Science , vol.277 , pp. 242-245
    • Lindahl, P.1    Johansson, B.R.2    Leveen, P.3    Betsholtz, C.4
  • 23
    • 0042125242 scopus 로고    scopus 로고
    • Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall
    • Lindblom P., Gerhardt H., Liebner S., et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17 (2003) 1835-1840
    • (2003) Genes Dev , vol.17 , pp. 1835-1840
    • Lindblom, P.1    Gerhardt, H.2    Liebner, S.3
  • 24
    • 14644446018 scopus 로고    scopus 로고
    • A multi-targeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is anti-angiogenic, producing objective responses and survival benefit in a mouse model of cancer
    • Pietras K., and Hanahan D. A multi-targeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is anti-angiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol 23 (2005) 939-952
    • (2005) J Clin Oncol , vol.23 , pp. 939-952
    • Pietras, K.1    Hanahan, D.2
  • 25
    • 1042301958 scopus 로고    scopus 로고
    • Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma
    • Apte S.M., Fan D., Killion J.J., and Fidler I.J. Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma. Clin Cancer Res 10 (2004) 897-908
    • (2004) Clin Cancer Res , vol.10 , pp. 897-908
    • Apte, S.M.1    Fan, D.2    Killion, J.J.3    Fidler, I.J.4
  • 26
    • 0034989658 scopus 로고    scopus 로고
    • Developmental roles of platelet-derived growth factors
    • Betsholtz C., Karlsson L., and Lindahl P. Developmental roles of platelet-derived growth factors. Bioessays 23 (2001) 494-507
    • (2001) Bioessays , vol.23 , pp. 494-507
    • Betsholtz, C.1    Karlsson, L.2    Lindahl, P.3
  • 27
    • 0027936261 scopus 로고
    • Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities
    • Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., and Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8 (1994) 1875-1887
    • (1994) Genes Dev , vol.8 , pp. 1875-1887
    • Leveen, P.1    Pekny, M.2    Gebre-Medhin, S.3    Swolin, B.4    Larsson, E.5    Betsholtz, C.6
  • 28
    • 27644479545 scopus 로고    scopus 로고
    • Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors
    • Thaker P.H., Yazici S., Nilsson M.B., et al. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. Clin Cancer Res 11 (2005) 4923-4933
    • (2005) Clin Cancer Res , vol.11 , pp. 4923-4933
    • Thaker, P.H.1    Yazici, S.2    Nilsson, M.B.3
  • 29
    • 0037567495 scopus 로고    scopus 로고
    • Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis
    • Langley R.R., Ramirez K.M., Tsan R.Z., Van Arsdall M., Nilsson M.B., and Fidler I.J. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 63 (2003) 2971-2976
    • (2003) Cancer Res , vol.63 , pp. 2971-2976
    • Langley, R.R.1    Ramirez, K.M.2    Tsan, R.Z.3    Van Arsdall, M.4    Nilsson, M.B.5    Fidler, I.J.6
  • 30
    • 4644315256 scopus 로고    scopus 로고
    • Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion
    • Sood A.K., Coffin J.E., Schneider G.B., et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol 165 (2004) 1087-1095
    • (2004) Am J Pathol , vol.165 , pp. 1087-1095
    • Sood, A.K.1    Coffin, J.E.2    Schneider, G.B.3
  • 31
    • 31544465011 scopus 로고    scopus 로고
    • Stress hormone-mediated invasion of ovarian cancer cells
    • Sood A.K., Bhatty R., Kamat A.A., et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12 (2006) 369-375
    • (2006) Clin Cancer Res , vol.12 , pp. 369-375
    • Sood, A.K.1    Bhatty, R.2    Kamat, A.A.3
  • 32
    • 0035071510 scopus 로고    scopus 로고
    • Molecular determinants of ovarian cancer plasticity
    • Sood A.K., Seftor E.A., Fletcher M.S., et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol 158 (2001) 1279-1288
    • (2001) Am J Pathol , vol.158 , pp. 1279-1288
    • Sood, A.K.1    Seftor, E.A.2    Fletcher, M.S.3
  • 33
    • 33947593200 scopus 로고    scopus 로고
    • American Cancer Society, Atlanta (GA)
    • Cancer facts and figures 2007 (2007), American Cancer Society, Atlanta (GA)
    • (2007) Cancer facts and figures 2007
  • 34
    • 0141688377 scopus 로고    scopus 로고
    • Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study
    • Ozols R.F., Bundy B.N., Greer B.E., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21 (2003) 3194-3200
    • (2003) J Clin Oncol , vol.21 , pp. 3194-3200
    • Ozols, R.F.1    Bundy, B.N.2    Greer, B.E.3
  • 35
    • 33644908789 scopus 로고    scopus 로고
    • Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment
    • Markman M., and Walker J.L. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J Clin Oncol 24 (2006) 988-994
    • (2006) J Clin Oncol , vol.24 , pp. 988-994
    • Markman, M.1    Walker, J.L.2
  • 36
    • 0032952010 scopus 로고    scopus 로고
    • Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    • Benjamin L.E., Golijanin D., Itin A., Pode D., and Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103 (1999) 159-165
    • (1999) J Clin Invest , vol.103 , pp. 159-165
    • Benjamin, L.E.1    Golijanin, D.2    Itin, A.3    Pode, D.4    Keshet, E.5
  • 37
    • 0035347301 scopus 로고    scopus 로고
    • Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
    • Reinmuth N., Liu W., Jung Y.D., et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15 (2001) 1239-1241
    • (2001) FASEB J , vol.15 , pp. 1239-1241
    • Reinmuth, N.1    Liu, W.2    Jung, Y.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.